Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform

  • Diagnostic and Analytics Company Aims to Revolutionize Laboratory Testing and Analytics

Genalyte, a leading diagnostics and analytics company, announced the closure of $50 million in financing.  Genalyte’s Maverick Diagnostic System (MDS) uses silicon chip based photonic ring resonance technology to perform multiple, simultaneous, rapid tests on a small volume of whole blood or serum in twenty minutes.

Recommended AI News: Samba TV Announces Real-time Picture Quality Innovation Powered by AI for Gaming, Movies, and Sports

“We are energized by the very enthusiastic response from Investors for this latest round of funding,” said CEO Ashraf Hanna.  “Genalyte is uniquely positioned to improve the laboratory diagnostic and analytic space.  We’ve demonstrated the strength of our technology in our EUA authorized SARS-CoV-2 Multi-Antigen Serology Panel, which is able to measure 26 different antibodies from one drop of blood.  Independent tests by the Mayo Clinic, Scripps, and Northshore Healthcare have consistently verified the platform’s industry leading capabilities.”

Related Posts
1 of 40,201

The financing round was led by Verily, an Alphabet company, and included current major investors Provenio Capital, Redmile, Khosla Ventures, HBM Partners, Samsara and others.

Recommended AI News: Daily AI Roundup: The 5 Coolest Things On Earth Today

Andy Conrad, CEO and founder of Verily has been nominated to Genalyte’s board of directors.  “Verily and Genalyte share a common vision of empowering physicians and patients with timely insights to improve outcomes and lower the cost of care,” said Andrew Conrad.  “I look forward to working with Genalyte as they continue to innovate technology to advance rapid diagnostics and analytics.”

The company intends to utilize the funding to expand the Maverick test menu and rapidly deploy the Maverick platform in clinical and retail settings.

Recommended AI News: Star Alliance Expands Strategic Partnership with TCS to Deliver Enhanced Customer Experiences

1 Comment
  1. Scrap Copper recycling centers Copper scrap forging Scrap metal reclamation handling
    Copper cable scrap applications, Scrap metal resource recovery, Environmental copper disposal

Leave A Reply

Your email address will not be published.